Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study
- PMID: 25259863
- PMCID: PMC4675453
- DOI: 10.1097/WNO.0000000000000167
Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study
Abstract
Background: Ocular motor abnormalities reflect the varied neuropathology of spinocerebellar ataxias (SCAs) and may serve to clinically distinguish the different SCAs. We analyzed the various eye movement abnormalities detected prospectively at the baseline visit during a large multicenter natural history study of SCAs 1, 2, 3, and 6.
Methods: The data were prospectively collected from 12 centers in the United States in patients with SCAs 1, 2, 3, and 6, as part of the Clinical Research Consortium for Spinocerebellar Ataxias (NIH-CRC-SCA). Patient characteristics, ataxia rating scales, the Unified Huntington Disease Rating Scale functional examination, and clinical staging were used. Eye movement abnormalities including nystagmus, disorders of saccades and pursuit, and ophthalmoparesis were recorded, and factors influencing their occurrence were examined.
Results: A total of 301 patients participated in this study, including 52 patients with SCA 1, 64 with SCA 2, 117 with SCA 3, and 68 with SCA 6. Although no specific ocular motor abnormality was pathognomonic to any SCA, significant differences were noted in their occurrence among different disorders. SCA 6 was characterized by frequent occurrence of nystagmus and abnormal pursuit and rarity of slow saccades and ophthalmoparesis and SCA 2 by the frequent occurrence of slow saccades and infrequent nystagmus and dysmetric saccades. SCA 1 and SCA 3 subjects had a more even distribution of eye movement abnormalities.
Conclusions: Prospective data from a large cohort of patients with SCAs 1, 2, 3, and 6 provide statistical validation that the SCAs exhibit distinct eye movement abnormalities that are useful in identifying the genotypes. Many of the abnormalities correlate with greater disease severity measures.
Conflict of interest statement
The remaining authors report no conflicts of interest.
References
-
- Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 2010;9:885–894. - PubMed
-
- Burk K, Stevanin G, Didierjean O, Cancel G, Trottier Y, Skalej M, Abele M, Brice A, Dichgans J, Klockgether T. Clinical and genetic analysis of three German kindreds with autosomal dominant cerebellar ataxia type 1 linked to the SCA2 locus. J Neurol. 1997;244:256–261. - PubMed
-
- Durr A, Smadja D, Cancel G, Lezin A, Stevanin G, Mikol J, Bellance GG, Cneiweiss H, Dellanave J. Autosomal dominant cerebellar ataxia type 1 in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain. 1995;118:1573–1581. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
